- FFR is reasonable to assess angiographic intermediate coronary lesions (50-70% diameter stenosis) and can be useful for guiding revascularization decisions in patients with stable ischemic heart disease (SIHD). (Class lla, Level of Evidence A).
CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan
- Jul 26, 2021
CathWorks Announces Appointment of Ramin Mousavi as Chief Executive Officer and Board Member
- Jun 14, 2021
CathWorks Announces $30 Million in New Financing
- Jan 08, 2021